Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Antitrust safe harbor review

This article was originally published in The Gray Sheet

Executive Summary

Senate Judiciary/Antitrust Subcommittee Ranking Member Herb Kohl (D-Wisc.) indicates his support for reworking the federal health care antitrust guidelines in May 21 release announcing Hew Pate's appointment as DoJ Assistant Attorney General for Antitrust. Kohl and Subcommittee Chair Mike DeWine (R-Ohio) had requested DoJ and FTC reexamine the "antitrust safety zone" at a GPO hearing last April (1"The Gray Sheet" May 6, 2002, p. 9). "While the Federal Trade Commission has taken the lead in investigating this industry, the Antitrust Division's cooperation in revising the joint FTC/DOJ Health Care Guidelines will be essential to restoring competition to this vital sector," Kohl says...

You may also be interested in...



GPO Self-Regulation Prescribed As Alternative To Congressional Action

Device manufacturers will have three months to help shape a code of conduct to be developed by group purchasing organization stakeholders

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018417

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel